Access to Orphan Drugs is a Challenge for Sustainable Management of Cystinosis in China.

Li, Xiao-Qiao; Peng, Xiao-Xia; Gong, Chun-Xiu

Li, Xiao-Qiao; Peng, Xiao-Xia; Gong, Chun-Xiu.

Afiliação

Li XQ; Beijing Key Laboratory for Genetics of Birth Defects, Center of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, The Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Peng XX; Center of Clinical Epidemiology and Evidence-Based Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health; Department of Epidemiology and Biostatistics, School of Public Health, Capital Medical University, Beijing 100045, China.
Gong CX; Beijing Key Laboratory for Genetics of Birth Defects, Center of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, The Capital Medical University, National Center for Children's Health, Beijing 100045, China.

Chin Med J (Engl) ; 131(19): 2388-2389, 2018 10 05.

Article em En | MEDLINE | ID: mdl-30246737

Assuntos

Cistinose/tratamento farmacológico; China; Cisteamina/uso terapêutico; Humanos; Masculino; Produção de Droga sem Interesse Comercial

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Cistinose Limite: Humans / Male País/Região como assunto: Asia Idioma: En Revista: Chin Med J (Engl) Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google